drugset / Trial / NCT02940535
Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response
RandomizedParallel-groupOpen-labelTreatment
Summary
The management of the poor responder patients is very difficult. Currently, there is no any standard treatment for poor responder patients. The study is designed to test a modified GnRHa protocol for poor ovarian response, low dose GnRHa early luteal phase down regulation, compare with GnRHa ultra-short protocol. This is a randomized controlled trial.
Timeline
- Start
- 2016-12
- Primary completion
- 2019-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | 0.1 mg | — |
| Subject | Triptorelin | Other / unclassified | 0.375 mg | — |
| Background | human chorionic gonadotropin | Protein / enzyme biologic | — | — |